![]() |
市場調查報告書
商品編碼
1856937
全球醫療設備連接市場:預測至 2032 年-按組件、部署方式、技術、應用、最終用戶和地區進行分析Medical Device Connectivity Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software, Services), Deployment Mode, Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2025 年,全球醫療設備連接市場規模將達到 34 億美元,到 2032 年將達到 121 億美元,預測期內複合年成長率為 20.1%。
醫療設備互聯是指醫療設備與醫療保健IT系統之間的整合和通訊,從而實現無縫資料交換和即時監測。這項技術使患者監護儀、輸液幫浦和人工呼吸器等設備能夠將關鍵資訊直接傳輸到電子健康記錄(EHR)系統,從而改善臨床工作流程和患者預後。透過自動化資料收集和減少人工輸入,它提高了醫療保健環境中的準確性、效率和決策能力。醫療設備互聯支援遠端監測、遠端醫療和跨平台互通性,使其成為現代數據主導醫療保健環境中至關重要的組成部分,該環境強調安全性、品質和卓越營運。
擴大電子健康記錄(EHR)的使用
電子健康記錄(EHR) 的日益普及是醫療設備互聯市場的主要驅動力。 EHR 系統需要與醫療設備無縫整合,以確保準確的即時數據收集並改善臨床工作流程。互聯功能可以增強患者監測、減少人為錯誤並支援更快的決策。隨著醫療服務提供者優先考慮數位轉型和數據互通性,對能夠直接與 EHR 平台連接的互聯設備的需求不斷成長,從而推動了全球市場的擴張。
高昂的實施成本
高昂的實施成本仍是醫療設備互聯市場的主要限制因素。將設備整合到IT系統中需要對硬體、軟體和專業人員進行大量投資。規模較小的醫療機構可能面臨預算限制,難以採用先進的互聯解決方案。此外,持續的維護和升級也會加重財務負擔。這些成本相關的挑戰會減緩市場滲透速度,尤其是在醫療技術基礎設施和資金有限的發展中地區。
技術進步
科技進步為醫療設備互聯市場的發展提供了巨大的機會。無線通訊、雲端運算和互通性標準的創新,使得設備整合更有效率且可擴展。物聯網和人工智慧等新技術增強了遠端監控和預測分析能力,從而改善了患者的治療效果。隨著醫療保健系統的現代化,對智慧連網型設備的需求日益成長。這些進步實現了無縫數據交換,減少了人工干預,並支持個人化護理,從而促進了市場在各種醫療保健環境中的擴張。
資料安全和隱私問題
資料安全和隱私問題嚴重阻礙了醫療設備互聯市場的成長。互聯設備間傳輸敏感的患者資料會增加網路攻擊和資料外洩的風險,從而導致潛在的法律責任和信任危機。由於需要遵守 HIPAA 和 GDPR 等法規,醫療服務提供者可能對採用互聯解決方案猶豫不決。這些顧慮會延緩整合進程,並增加互聯系統安全保障的成本和複雜性。
新冠疫情顯著加速了醫療設備互聯技術的應用。隨著遠端患者監護和遠端醫療服務的普及,醫療機構越來越依賴連網設備在傳統診療環境之外進行診療工作。此次疫情凸顯了即時數據交換和互通性的重要性,並刺激了對數位基礎設施的投資。儘管供應鏈中斷初期影響了設備的可得性,但從長遠來看,其影響是積極的,提高了人們對互聯解決方案的認知和需求,從而推動了創新和市場成長。
預計在預測期內,輸液幫浦細分市場將成為最大的細分市場。
由於輸液幫浦在醫院和診所中被廣泛用於精準給藥,預計在預測期內,輸液幫浦細分市場將佔據最大的市場佔有率。這些設備需要可靠的連接,以確保準確的劑量追蹤並與電子病歷系統整合。隨著慢性病管理和住院治療需求的不斷成長,輸液幫浦在提高治療效率和安全性方面發揮著至關重要的作用。它們與各種連接平台的兼容性使其成為現代醫療工作流程的基石。
預計在預測期內,麻醉儀器細分市場將實現最高的複合年成長率。
由於手術量的增加和對先進監測技術的需求,麻醉儀器領域預計將在預測期內實現最高成長率。互聯技術能夠將麻醉儀器的即時資料傳輸至電子病歷系統 (EHR),從而提升病患安全和臨床決策水準。機器設計和整合能力的創新使這些設備更能適應互聯環境。隨著醫院在手術室中日益重視精準性和自動化,連網麻醉儀器的應用預計將迅速成長。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於快速的都市化、不斷擴大的醫療基礎設施以及對數位醫療技術日益成長的投資。中國、印度和日本等國家正在採用互聯醫療解決方案,以改善患者療效並提高營運效率。政府支持醫療資訊技術應用的舉措以及領先醫療設備製造商的存在,進一步鞏固了該地區在全球市場的主導地位。
預計北美在預測期內將實現最高的複合年成長率。這主要得益於該地區先進的醫療基礎設施、健全的法規結構以及電子病歷(EHR)系統的高普及率,這些因素共同推動了北美地區的快速成長。對病患安全、資料互通性和遠端監控的日益重視,也推動了對連網型設備的需求。此外,主要市場參與者的存在以及持續的技術創新,使北美成為醫療保健領域尖端互聯解決方案的中心。
According to Stratistics MRC, the Global Medical Device Connectivity Market is accounted for $3.4 billion in 2025 and is expected to reach $12.1 billion by 2032 growing at a CAGR of 20.1% during the forecast period. Medical Device Connectivity refers to the integration and communication of medical devices with healthcare IT systems, enabling seamless data exchange and real-time monitoring. This technology allows devices such as patient monitors, infusion pumps, and ventilators to transmit vital information directly to electronic health records (EHRs), improving clinical workflows and patient outcomes. By automating data capture and reducing manual entry, it enhances accuracy, efficiency, and decision-making in healthcare settings. Medical device connectivity supports remote monitoring, telehealth, and interoperability across platforms, making it a critical component in modern, data-driven healthcare environments focused on safety, quality, and operational excellence.
Growing Adoption of Electronic Health Records (EHRs)
The increasing adoption of Electronic Health Records (EHRs) is a major driver of the medical device connectivity market. EHR systems require seamless integration with medical devices to ensure accurate, real-time data capture and improved clinical workflows. Connectivity enhances patient monitoring, reduces manual errors, and supports faster decision-making. As healthcare providers prioritize digital transformation and data interoperability, the demand for connected devices that can interface directly with EHR platforms continues to rise, fueling market expansion globally.
High Implementation Costs
High implementation costs remain a significant restraint in the medical device connectivity market. Integrating devices with IT systems involves substantial investment in hardware, software, and skilled personnel. Smaller healthcare facilities may struggle with budget constraints, limiting their ability to adopt advanced connectivity solutions. Additionally, ongoing maintenance and upgrades add to the financial burden. These cost-related challenges can slow market penetration, especially in developing regions where infrastructure and funding for healthcare technology are limited.
Technological Advancements
Technological advancements present a strong opportunity for growth in the medical device connectivity market. Innovations in wireless communication, cloud computing, and interoperability standards are making device integration more efficient and scalable. Emerging technologies like IoT and AI enhance remote monitoring and predictive analytics, improving patient outcomes. As healthcare systems modernize, the demand for smart, connected devices grows. These advancements enable seamless data exchange, reduce manual intervention, and support personalized care, driving market expansion across diverse medical settings.
Data Security and Privacy Concerns
Data security and privacy concerns significantly hinder the growth of the medical device connectivity market. The transmission of sensitive patient data across connected devices raises risks of cyberattacks and data breaches, leading to potential legal liabilities and loss of trust. Healthcare providers may hesitate to adopt connectivity solutions due to compliance challenges with regulations like HIPAA and GDPR. These concerns slow integration efforts and increase the cost and complexity of securing connected systems.
The COVID-19 pandemic significantly accelerated the adoption of medical device connectivity. With the surge in remote patient monitoring and telehealth services, healthcare providers relied heavily on connected devices to manage care outside traditional settings. The crisis highlighted the importance of real-time data exchange and interoperability, prompting investments in digital infrastructure. While supply chain disruptions initially affected device availability, the long-term impact has been positive, with increased awareness and demand for connectivity solutions driving innovation and market growth.
The infusion pumps segment is expected to be the largest during the forecast period
The infusion pumps segment is expected to account for the largest market share during the forecast period, owing to its widespread use in hospitals and clinics for precise drug delivery. These devices require reliable connectivity to ensure accurate dosage tracking and integration with EHR systems. As chronic disease management and inpatient care demand grow, infusion pumps play a critical role in improving treatment efficiency and safety. Their compatibility with connectivity platforms makes them a cornerstone of modern healthcare workflows.
The anesthesia machines segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the anesthesia machines segment is predicted to witness the highest growth rate, due to increasing surgical procedures and demand for advanced monitoring. Connectivity enables real-time data transmission from anesthesia machines to EHRs, enhancing patient safety and clinical decision-making. Innovations in machine design and integration capabilities are making these devices more adaptable to connected environments. As hospitals prioritize precision and automation in operating rooms, the adoption of connected anesthesia machines is expected to surge rapidly.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, because rapid urbanization, expanding healthcare infrastructure, and growing investments in digital health technologies are driving demand. Countries like China, India, and Japan are embracing connected healthcare solutions to improve patient outcomes and operational efficiency. Government initiatives supporting health IT adoption and the presence of major medical device manufacturers further strengthen the region's dominant position in the global market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, because region's advanced healthcare infrastructure, strong regulatory framework, and high adoption of EHR systems contribute to rapid growth. Increasing focus on patient safety, data interoperability, and remote monitoring fuel demand for connected devices. Additionally, the presence of key market players and ongoing technological innovation make North America a hub for cutting-edge connectivity solutions in healthcare.
Key players in the market
Some of the key players in Medical Device Connectivity Market include Medtronic, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, Boston Scientific, GE Healthcare, Philips Healthcare, Siemens Healthineers, Becton, Dickinson and Company (BD), Masimo Corporation, Hillrom (Baxter International), Cerner Corporation, Capsule Technologies, Smiths Medical, Nihon Kohden
In March 2025, Cadrenal Therapeutics has partnered with Abbott to advance tecarfarin, a novel oral anticoagulant, through a pivotal Phase 3 trial (TECH-LVAD) for patients with Left Ventricular Assist Devices (LVADs). Abbott will support trial design, site identification, and provide expertise on the HeartMate 3(TM) LVAD, the only LVAD approved in the U.S. Tecarfarin has received FDA Orphan Drug Designation for preventing thromboembolism in LVAD patients, aiming to offer a safer and more effective alternative to warfarin.
In December 2024, Abbott Laboratories and DexCom have resolved all ongoing patent disputes concerning continuous glucose monitoring devices. The settlement includes the dismissal of all pending cases worldwide and a mutual commitment to refrain from future patent or appearance-related legal actions for the next decade.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.